Fibryna bogatopłytkowa – współczesne spojrzenie na jej zastosowania w medycynie estetycznej i stomatologii
DOI:
https://doi.org/10.20883/jofa.67Słowa kluczowe:
fibryna bogatopłytkowa, PRF, medycyna estetycznaAbstrakt
Wstęp i cel. W ostatnich latach wzrasta popularność fibryny bogatopłytkowej stosowanej w zabiegach chirurgii szczękowo‑twarzowej i medycynie estetycznej. W prezentowanym artykule przedstawiono przegląd i podsumowanie bieżącego medycznego piśmiennictwa odnoszącego się do zastosowań tego preparatu.
Materiał i metody. Przeprowadzono przegląd bieżących, angielskojęzycznych publikacji medycznych w bazie danych PubMed, używając fraz: „PRF”, „platelet‑rich fibrin in aesthetic medicine”, „platelet‑rich fibrin in dentistry”.
Wyniki i wnioski. PRF jako preparat autologiczny, tani i łatwy do uzyskania, który można zastosować w wielu zabiegach medycyny estetycznej i stomatologii, może stanowić o przyszłości tych gałęzi medycyny. W najbliższych latach należy jednak zwrócić uwagę na przeprowadzenie bardziej szczegółowych badań efektów tej terapii, gdyż większośc dotychczasowych oparta została na małych grupach pacjentów, z krótkim okresem follow‑up lub zawiera błędy w projekcie badawczym.
Pobrania
Bibliografia
Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018 Sep;29(6):556-568. doi: 10.1080/09537104.2018.1430357. Epub 2018 Feb 14. PMID: 29442539.
Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review. Rev Endocr Metab Disord. 2019 Jun;20(2):207-217. doi: 10.1007/s11154-019-09492-1. PMID: 30937614.
Ramaswamy Reddy SH, Reddy R, Babu NC, Ashok GN. Stem‑cell therapy and platelet‑rich plasma in regenerative medicines: A review on pros and cons of the technologies. J Oral Maxillofac Pathol. 2018 Sep‑Dec;22(3):367-374. doi: 10.4103/jomfp.JOMFP_93_18. PMID: 30651682; PMCID: PMC6306612.
Gentile RD. Easy Platelet‑Rich Fibrin (Injectable/Topical) for Post‑resurfacing and Microneedle Therapy. Facial Plast Surg Clin North Am. 2020 Feb;28(1):127-134. doi: 10.1016/j.fsc.2019.09.011. PMID: 31779936.
Pavlovic V, Ciric M, Jovanovic V, Trandafilovic M, Stojanovic P. Platelet‑rich fibrin: Basics of biological actions and protocol modifications. Open Med (Wars). 2021 Mar 22;16(1):446-454. doi: 10.1515/med-2021-0259. PMID: 33778163; PMCID: PMC7985567.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet‑rich fibrin (PRF): a second‑generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e37-44. doi: 10.1016/j.tripleo.2005.07.008. Epub 2006 Jan 19. PMID: 16504849.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet‑rich fibrin (PRF): a second‑generation platelet concentrate. Part II: platelet‑related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e45-50. doi: 10.1016/j.tripleo.2005.07.009. Epub 2006 Jan 10. PMID: 16504850.
Pietruszka P, Chruścicka I, Duś‑Ilnicka I, Paradowska‑Stolarz A. PRP and PRF‑Subgroups and Divisions When Used in Dentistry. J Pers Med. 2021 Sep 23;11(10):944. doi: 10.3390/jpm11100944. PMID: 34683085; PMCID: PMC8540475.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL i wsp. Platelet‑rich fibrin (PRF): a second‑generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. doi: 10.1016/j.tripleo.2005.07.011. PMID: 16504852.
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet‑rich plasma (P‑PRP) to leucocyte- and platelet‑rich fibrin (L‑PRF). Trends Biotechnol. 2009 Mar;27(3):158-67. doi: 10.1016/j.tibtech.2008.11.009. Epub 2009 Jan 31. PMID: 19187989.
Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet‑rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009 Feb;27(1):63-9. doi: 10.1080/08977190802636713. PMID: 19089687.
He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet‑rich fibrin (PRF) and platelet‑rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Nov;108(5):707-13. doi: 10.1016/j.tripleo.2009.06.044. PMID: 19836723.
de Boer HC, Verseyden C, Ulfman LH, Zwaginga JJ, Bot I, Biessen EA, Rabelink TJ, van Zonneveld AJ. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1653-9. doi: 10.1161/01.ATV.0000222982.55731.f1. Epub 2006 Apr 20. PMID: 16627804.
Yu P, Zhai Z, Jin X, Yang X, Qi Z. Clinical Application of Platelet‑Rich Fibrin in Plastic and Reconstructive Surgery: A Systematic Review. Aesthetic Plast Surg. 2018 Apr;42(2):511-519. doi: 10.1007/s00266-018-1087-0. Epub 2018 Feb 2. PMID: 29396591.
Lavagen N, Nokovitch L, Algrin A, Dakpe S, Testelin S, Devauchelle B, Gbaguidi C. Efficiency of advanced‑PRF usage in the treatment of alveolar cleft with iliac bone graft: A retrospective study. J Craniomaxillofac Surg. 2021 Oct;49(10):923-928. doi: 10.1016/j.jcms.2021.06.001. Epub 2021 Jun 8. PMID: 34158223.
Lektemur Alpan A, Torumtay Cin G. PRF improves wound healing and postoperative discomfort after harvesting subepithelial connective tissue graft from palate: a randomized controlled trial. Clin Oral Investig. 2020 Jan;24(1):425-436. doi: 10.1007/s00784-019-02934-9. Epub 2019 May 18. PMID: 31104113.
Al‑Maawi S, Dohle E, Lim J, Weigl P, Teoh SH, Sader R, Ghanaati S. Biologization of Pcl‑Mesh Using Platelet Rich Fibrin (Prf) Enhances Its Regenerative Potential In Vitro. Int J Mol Sci. 2021 Feb 22;22(4):2159. doi: 10.3390/ijms22042159. PMID: 33671550; PMCID: PMC7926906.
Miron RJ, Moraschini V, Fujioka‑Kobayashi M, Zhang Y, Kawase T, Cosgarea R i wsp. Use of platelet‑rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta‑analysis. Clin Oral Investig. 2021 May;25(5):2461-2478. doi: 10.1007/s00784-021-03825-8. Epub 2021 Feb 20. PMID: 33609186; PMCID: PMC8060184.
Alrayyes Y, Al‑Jasser R. Regenerative Potential of Platelet Rich Fibrin (PRF) in Socket Preservation in Comparison with Conventional Treatment Modalities: A Systematic Review and Meta‑Analysis. Tissue Eng Regen Med. 2022 Jun;19(3):463-475. doi: 10.1007/s13770-021-00428-y. Epub 2022 Mar 25. PMID: 35334092; PMCID: PMC9130396..
Giannini S, Cielo A, Bonanome L, Rastelli C, Derla C, Corpaci F, Falisi G. Comparison between PRP, PRGF and PRF: lights and shadows in three similar but different protocols. Eur Rev Med Pharmacol Sci. 2015;19(6):927-30. PMID: 25855914.
Fan Y, Perez K, Dym H. Clinical Uses of Platelet‑Rich Fibrin in Oral and Maxillofacial Surgery. Dent Clin North Am. 2020 Apr;64(2):291-303. doi: 10.1016/j.cden.2019.12.012. Epub 2020 Feb 3. PMID: 32111269.
Pitzurra L, Jansen IDC, de Vries TJ, Hoogenkamp MA, Loos BG. Effects of L‑PRF and A‑PRF+ on periodontal fibroblasts in in vitro wound healing experiments. J Periodontal Res. 2020 Apr;55(2):287-295. doi: 10.1111/jre.12714. Epub 2019 Nov 28. PMID: 31782171; PMCID: PMC7154757.
Agrawal AA. Evolution, current status and advances in application of platelet concentrate in periodontics and implantology. World J Clin Cases. 2017 May 16;5(5):159-171. doi: 10.12998/wjcc.v5.i5.159. PMID: 28560233; PMCID: PMC5434315.
Mourão CF, Valiense H, Melo ER, Mourão NB, Maia MD. Obtention of injectable platelets rich‑fibrin (i‑PRF) and its polymerization with bone graft: technical note. Rev Col Bras Cir. 2015 Nov‑Dec;42(6):421-3. English, Portuguese. doi: 10.1590/0100-69912015006013. PMID: 26814997.
Castro AB, Andrade C, Li X, Pinto N, Teughels W, Quirynen M. Impact of g force and timing on the characteristics of platelet‑rich fibrin matrices. Sci Rep. 2021 Mar 16;11(1):6038. doi: 10.1038/s41598-021-85736-y. PMID: 33727689; PMCID: PMC7971031.
Lu K, Han Q, Ma Z, Yan Q, Pei Y, Shi P i wsp.. Injectable platelet rich fibrin facilitates hair follicle regeneration by promoting human dermal papilla cell proliferation, migration, and trichogenic inductivity. Exp Cell Res. 2021 Dec 1;409(1):112888. doi: 10.1016/j.yexcr.2021.112888. Epub 2021 Oct 26. PMID: 34715152.
Bukhari SNA, Roswandi NL, Waqas M, Habib H, Hussain F, Khan S, i wsp. Hyaluronic acid, a promising skin rejuvenating biomedicine: A review of recent updates and pre‑clinical and clinical investigations on cosmetic and nutricosmetic effects. Int J Biol Macromol. 2018 Dec;120(Pt B):1682-1695. doi: 10.1016/j.ijbiomac.2018.09.188. Epub 2018 Oct 1. PMID: 30287361.
Karimi K, Rockwell H. The Benefits of Platelet‑Rich Fibrin. Facial Plast Surg Clin North Am. 2019 Aug;27(3):331-340. doi: 10.1016/j.fsc.2019.03.005. PMID: 31280847.
Azoury SC, Shakir S, Bucky LP, Percec I. Modern Fat Grafting Techniques to the Face and Neck. Plast Reconstr Surg. 2021 Oct 1;148(4):620e-633e. doi: 10.1097/PRS.0000000000008405. PMID: 34550946.
Zhang ZX, Qiu LH, Shi N, Xiong SH, Ma XJ, Yi CG. Platelet‑Rich Fibrin in Fat Grafts for Facial Lipofilling: A Randomized, Controlled Split‑Face Clinical Trial. Front Surg. 2022 Apr 13;9:793439. doi: 10.3389/fsurg.2022.793439. PMID: 35495758; PMCID: PMC9043459.
Wei H, Gu SX, Liang YD, Liang ZJ, Chen H, Zhu MG i wsp.. Nanofat‑derived stem cells with platelet‑rich fibrin improve facial contour remodeling and skin rejuvenation after autologous structural fat transplantation. Oncotarget. 2017 Jul 31;8(40):68542-68556. doi: 10.18632/oncotarget.19721. PMID: 28978136; PMCID: PMC5620276.
Liang ZJ, Lu X, Li DQ, Liang YD, Zhu DD, Wu FX i wsp. Precise Intradermal Injection of Nanofat‑Derived Stromal Cells Combined with Platelet‑Rich Fibrin Improves the Efficacy of Facial Skin Rejuvenation. Cell Physiol Biochem. 2018;47(1):316-329. doi: 10.1159/000489809. Epub 2018 May 11. PMID: 29768259.
Hamid O, Quinlan DJ, Seemann R, Hassan H. Injectable platelet‑rich fibrin for perioral rejuvenation as assessed by 3D lip volume imaging. J Cosmet Dermatol. 2021 Oct;20(10):3270-3277. doi: 10.1111/jocd.14394. Epub 2021 Sep 24. PMID: 34559947.
Nacopoulos C, Vesala AM. Lower facial regeneration with a combination of platelet‑rich fibrin liquid matrices based on the low speed centrifugation concept‑Cleopatra technique. J Cosmet Dermatol. 2020 Jan;19(1):185-189. doi: 10.1111/jocd.13196. Epub 2019 Nov 1. PMID: 31674154.
Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet‑rich fibrin in the treatment of intra‑bony defects: a controlled clinical trial. J Clin Periodontol. 2011 Oct;38(10):925-32. doi: 10.1111/j.1600-051X.2011.01760.x. Epub 2011 Jul 21. PMID: 21777267.
Simonpieri A, Del Corso M, Vervelle A, Jimbo R, Inchingolo F, Sammartino G, Dohan Ehrenfest DM. Current knowledge and perspectives for the use of platelet‑rich plasma (PRP) and platelet‑rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol. 2012 Jun;13(7):1231-56. doi: 10.2174/138920112800624472. PMID: 21740370.
Shawky H, Seifeldin SA. Does Platelet‑Rich Fibrin Enhance Bone Quality and Quantity of Alveolar Cleft Reconstruction? Cleft Palate Craniofac J. 2016 Sep;53(5):597-606. doi: 10.1597/14-290. Epub 2015 Oct 9. PMID: 26451499.
Öncü E. The Use of Platelet‑Rich Fibrin Versus Subepithelial Connective Tissue Graft in Treatment of Multiple Gingival Recessions: A Randomized Clinical Trial. Int J Periodontics Restorative Dent. 2017 Mar/Apr;37(2):265-271. doi: 10.11607/prd.2741. PMID: 28196169.
Aroca S, Keglevich T, Barbieri B, Gera I, Etienne D. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet‑rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol. 2009 Feb;80(2):244-52. doi: 10.1902/jop.2009.080253. PMID: 19186964.
Del Corso M, Sammartino G, Dohan Ehrenfest DM. Re: „Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet‑rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study”. J Periodontol. 2009 Nov;80(11):1694-7; author reply 1697-9. doi: 10.1902/jop.2009.090253. PMID: 19905939.
Eren G, Atilla G. Platelet‑rich fibrin in the treatment of localized gingival recessions: a split‑mouth randomized clinical trial. Clin Oral Investig. 2014 Nov;18(8):1941-8. doi: 10.1007/s00784-013-1170-5. Epub 2013 Dec 22. PMID: 24362634.
Canellas JVDS, Medeiros PJD, Figueredo CMDS, Fischer RG, Ritto FG. Platelet‑rich fibrin in oral surgical procedures: a systematic review and meta‑analysis. Int J Oral Maxillofac Surg. 2019 Mar;48(3):395-414. doi: 10.1016/j.ijom.2018.07.007. Epub 2018 Jul 30. PMID: 30072300.
Ghanaati S, Herrera‑Vizcaino C, Al‑Maawi S, Lorenz J, Miron RJ, Nelson K i wsp. Fifteen Years of Platelet Rich Fibrin in Dentistry and Oromaxillofacial Surgery: How High is the Level of Scientific Evidence? J Oral Implantol. 2018 Dec;44(6):471-492. doi: 10.1563/aaid‑joi‑D-17-00179. Epub 2018 Jun 5. PMID: 29870308.
Tajima N, Ohba S, Sawase T, Asahina I. Evaluation of sinus floor augmentation with simultaneous implant placement using platelet‑rich fibrin as sole grafting material. Int J Oral Maxillofac Implants. 2013 Jan‑Feb;28(1):77-83. doi: 10.11607/jomi.2613. PMID: 23377050.
Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet‑rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol. 2009 Dec;80(12):2056-64. doi: 10.1902/jop.2009.090252. PMID: 19961389.
Simonpieri A, Choukroun J, Del Corso M, Sammartino G, Dohan Ehrenfest DM. Simultaneous sinus‑lift and implantation using microthreaded implants and leukocyte- and platelet‑rich fibrin as sole grafting material: a six‑year experience. Implant Dent. 2011 Feb;20(1):2-12. doi: 10.1097/ID.0b013e3181faa8af. PMID: 21278521.
Inchingolo F, Tatullo M, Marrelli M, Inchingolo AM, Scacco S, Inchingolo AD, Dipalma G, Vermesan D, Abbinante A, Cagiano R. Trial with Platelet‑Rich Fibrin and Bio‑Oss used as grafting materials in the treatment of the severe maxillar bone atrophy: clinical and radiological evaluations. Eur Rev Med Pharmacol Sci. 2010 Dec;14(12):1075-84. PMID: 21375140.
Pobrania
Opublikowane
Numer
Dział
Licencja
Prawa autorskie (c) 2023 Prawa autorskie do nadesłanego manuskryptu przysługują Autorowi, który udziela Journal of Medical Science (JMS) niewyłącznej licencji na wykorzystanie, reprodukcję i rozpowszechnianie utworu, w tym w celach komercyjnych.
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.
